We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Lab Research Advances with Cell-Based Gene Expression Analysis Kits

By Biotechdaily staff writers
Posted on 30 Apr 2008
New gene expression kits can eliminate the time-consuming step of RNA purification, reducing the amount of time that is typically necessary to prepare and analyze RNA from cultured cells using real-time polymerase chain reaction (PCR) in applications such as siRNA-mediated gene silencing and microRNA analysis.

Applied Biosystems (Foster City, CA, USA) has launched a new family of TaqMan Cells-to-CT kits for performing cell-based gene expression research more rapidly. More...
The TaqMan Cells-to-CT kits allow expression analysis to be performed directly from cultured mammalian cells derived from a variety of tissue sources, including epithelial cells and stem cells. Sample preparation time is reduced to less than 10 minutes, compared to the traditionally required 30 to 60 minutes, and loss of RNA is eliminated.

The kits incorporate the gold standard TaqMan chemistry, forming part of a complete workflow that has been designed with all the necessary reagents for performing expression analysis and are validated for use with the Applied Biosystems' TaqMan assays and arrays. The family includes kits for gene expression analysis from mRNA; pre-amplification of selected targets; microRNA expression analysis; and gene expression analysis with fast real-time PCR.

Reproductive Medicine Associates of New Jersey, USA (Englewood, USA), one of the world's largest and most experienced centers for infertility treatment, focuses on developing new diagnostics and therapeutics for in vitro fertilization. Scientists at the center have developed an innovative research procedure for screening all 46 human chromosomes to identify abnormalities in embryos, and have begun to determine when stem cells differentiate during pre-implantation embryonic development. They are using the TaqMan Gene Expression Cells-to-CT kit for several projects, including the characterization of single cells in three-day old embryos, saving valuable time in the workflow.

"The use of real-time PCR is critical to our ability to perform expression analysis on stem cells,” said Nathan Treff, Ph.D., director of molecular biology at Reproductive Medicine Associates of New Jersey. "Using the TaqMan Gene Expression Cells-to-CT kit and TaqMan arrays, we have been able to improve the efficiency of our real-time PCR workflow and increase the throughput of our lab by 10-fold.”

Applied Biosystems is a developer and marketer of instrument-based systems, consumables, software, and services for the life-science market. The company's comprehensive line of real-time PCR chemistries and instrument systems includes the Applied Biosystems 7900HT Fast Real-Time PCR system, 7500 Real-Time PCR system, 7500 Fast Real-Time PCR system, 7300 Real-time PCR system, StepOne Real-Time PCR system, and StepOnePlus Real-Time PCR system.


Related Links:
Applied Biosystems

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.